
Olga V. Tcherkasskaya
Examiner (ID: 5403, Phone: (571)270-3672 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 928 |
| Issued Applications | 461 |
| Pending Applications | 124 |
| Abandoned Applications | 380 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10405099
[patent_doc_number] => 20150290108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'COSMETIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/688575
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9580
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/688575 | COSMETIC COMPOSITION | Apr 15, 2015 | Abandoned |
Array
(
[id] => 10428825
[patent_doc_number] => 20150313837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'POLYMERIC HYDROGEL COMPOSITIONS WHICH RELEASE ACTIVE AGENTS IN RESPONSE TO ELECTRICAL STIMULUS'
[patent_app_type] => utility
[patent_app_number] => 14/678618
[patent_app_country] => US
[patent_app_date] => 2015-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12084
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14678618
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/678618 | POLYMERIC HYDROGEL COMPOSITIONS WHICH RELEASE ACTIVE AGENTS IN RESPONSE TO ELECTRICAL STIMULUS | Apr 2, 2015 | Abandoned |
Array
(
[id] => 16572121
[patent_doc_number] => 10894032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Microbial-relief composition
[patent_app_type] => utility
[patent_app_number] => 14/671841
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 43
[patent_no_of_words] => 18233
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671841
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671841 | Microbial-relief composition | Mar 26, 2015 | Issued |
Array
(
[id] => 11778139
[patent_doc_number] => 09387173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 14/658285
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20237
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14658285
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/658285 | Pharmaceutical formulation containing gelling agent | Mar 15, 2015 | Issued |
Array
(
[id] => 14791357
[patent_doc_number] => 10398663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Mitochondrial delivery of 3-bromopyruvate
[patent_app_type] => utility
[patent_app_number] => 15/123786
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 10273
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123786
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/123786 | Mitochondrial delivery of 3-bromopyruvate | Mar 12, 2015 | Issued |
Array
(
[id] => 10297470
[patent_doc_number] => 20150182469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product'
[patent_app_type] => utility
[patent_app_number] => 14/657151
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18856
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14657151
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/657151 | Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product | Mar 12, 2015 | Abandoned |
Array
(
[id] => 10289080
[patent_doc_number] => 20150174078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Sustained Release Formulations of Lorazepam'
[patent_app_type] => utility
[patent_app_number] => 14/639027
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8814
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/639027 | Sustained Release Formulations of Lorazepam | Mar 3, 2015 | Abandoned |
Array
(
[id] => 10365813
[patent_doc_number] => 20150250818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Composition and Method of Using Medicament for Treatment of Cancers and Tumors'
[patent_app_type] => utility
[patent_app_number] => 14/637435
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11401
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14637435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/637435 | Composition and method of using medicament for treatment of cancers and tumors | Mar 3, 2015 | Issued |
Array
(
[id] => 10353659
[patent_doc_number] => 20150238664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'ANTITHROMBOTIC MEDICAL MATERIALS AND MEDICAL APPARATUS USING THE SAME MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 14/627351
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7983
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627351
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627351 | Antithrombotic medical materials and medical apparatus using the same materials | Feb 19, 2015 | Issued |
Array
(
[id] => 10654738
[patent_doc_number] => 20160000881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Oral Drug Devices and Drug Formulations'
[patent_app_type] => utility
[patent_app_number] => 14/620917
[patent_app_country] => US
[patent_app_date] => 2015-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19209
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14620917
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/620917 | Oral Drug Devices and Drug Formulations | Feb 11, 2015 | Abandoned |
Array
(
[id] => 11323898
[patent_doc_number] => 20160354509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'DEVICES FOR AND METHODS OF TREATMENT OF METABOLIC SYNDROMES'
[patent_app_type] => utility
[patent_app_number] => 15/117715
[patent_app_country] => US
[patent_app_date] => 2015-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10766
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117715
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/117715 | DEVICES FOR AND METHODS OF TREATMENT OF METABOLIC SYNDROMES | Feb 9, 2015 | Abandoned |
Array
(
[id] => 10262394
[patent_doc_number] => 20150147391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 14/611716
[patent_app_country] => US
[patent_app_date] => 2015-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20210
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14611716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/611716 | Pharmaceutical Formulation Containing Gelling Agent | Feb 1, 2015 | Abandoned |
Array
(
[id] => 10255086
[patent_doc_number] => 20150140083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 14/605034
[patent_app_country] => US
[patent_app_date] => 2015-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20209
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/605034 | Pharmaceutical Formulation Containing Gelling Agent | Jan 25, 2015 | |
Array
(
[id] => 11815028
[patent_doc_number] => 09718970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Core-shell metal nanoparticle composite'
[patent_app_type] => utility
[patent_app_number] => 14/604598
[patent_app_country] => US
[patent_app_date] => 2015-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 6953
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/604598 | Core-shell metal nanoparticle composite | Jan 22, 2015 | Issued |
Array
(
[id] => 11296661
[patent_doc_number] => 09504654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Immediate release film coatings containing medium chain glycerides and substrates coated therewith'
[patent_app_type] => utility
[patent_app_number] => 14/597025
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4962
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14597025
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/597025 | Immediate release film coatings containing medium chain glycerides and substrates coated therewith | Jan 13, 2015 | Issued |
Array
(
[id] => 10435699
[patent_doc_number] => 20150320711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'Capsules Containing High Doses of Levodopa for Pulmonary Use'
[patent_app_type] => utility
[patent_app_number] => 14/575454
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10034
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/575454 | Capsules containing high doses of levodopa for pulmonary use | Dec 17, 2014 | Issued |
Array
(
[id] => 10978279
[patent_doc_number] => 20160175222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'WATERPROOF MASCARA COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/573865
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7155
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14573865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/573865 | WATERPROOF MASCARA COMPOSITION | Dec 16, 2014 | Abandoned |
Array
(
[id] => 11099484
[patent_doc_number] => 20160296454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'Hair Fixatives Including Starch Ester Based Polyglucose Polymers'
[patent_app_type] => utility
[patent_app_number] => 15/100675
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8056
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15100675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/100675 | Hair fixatives including starch ester based polyglucose polymers | Dec 16, 2014 | Issued |
Array
(
[id] => 11920980
[patent_doc_number] => 09788541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Antibacterial surfactant/microgel formulations, methods of making and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 14/567128
[patent_app_country] => US
[patent_app_date] => 2014-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 11482
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14567128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/567128 | Antibacterial surfactant/microgel formulations, methods of making and methods of using the same | Dec 10, 2014 | Issued |
Array
(
[id] => 10279856
[patent_doc_number] => 20150164853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'PROSTACYCLIN COMPOSITIONS FOR REGULATION OF FRACTURE REPAIR AND BONE FORMATION'
[patent_app_type] => utility
[patent_app_number] => 14/563754
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13143
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/563754 | Prostacyclin compositions for regulation of fracture repair and bone formation | Dec 7, 2014 | Issued |